Results (4282)
Long-term, Non-interventional Study of Recipients of Tecartus for Treatment of Adult Patients With Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL) or Adult Patients With R/R B-Cell Precursor Acute Lymphoblastic Leukemia (ALL)
Austria
Czechia
France
Germany
Israel
Italy
Netherlands
Poland
Portugal
Spain
Switzerland
United Kingdom
United States
EU PAS number:
EUPAS45813
First published:
15/05/2025
StudyOngoing
DARWIN EU® - Characterising the use of JAK inhibitors in Europe: a Drug Utilisation Study
Finland
Germany
Netherlands
Norway
Spain
EU PAS number:
EUPAS1000000424
First published:
15/05/2025
StudyFinalised
DARWIN EU® - Prevalence of hypertrophic cardiomyopathy (HCM) and obstructive hypertrophic cardiomyopathy (oHCM) in six European countries
Croatia
Denmark
Germany
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000430
First published:
14/05/2025
StudyFinalised
CLINICAL RESEARCH UNIT, SCHOOL OF MEDICINE, PAPAGEORGIOU GENERAL HOSPITAL, ARISTOTLE UNIVERSITY OF THESSALONIKI (CRU-AUSoM)
Greece
First published:
13/05/2025
InstitutionEducational InstitutionHospital/Clinic/Other health care facilityLaboratory/Research/Testing facilityENCePP partner
Drug Utilization Study Evaluating Additional Risk Minimisation Measures for Upadacitinib in the Treatment of Ulcerative Colitis in Europe
Denmark
Spain
Sweden
EU PAS number:
EUPAS107885
First published:
12/05/2025
StudyOngoing
Real-world Study on Bemiparin Effect in Patients with Cancer-Associated Thromboembolism Using Artificial Intelligence (BEMICAT Study)
Spain
EU PAS number:
EUPAS1000000578
First published:
12/05/2025
StudyOngoing
Prospective non-interventional cohort study to assess safety and tolerability of 3Fluart 2025/2026 trivalent seasonal influenza vaccine in children, adolescents, adults and elderly subjects (3Fluart-H-36)
Hungary
EU PAS number:
EUPAS1000000581
First published:
12/05/2025
StudyPlanned
Clinical Characteristics, Including History of MI and Stroke, Among US Post-menopausal Women Initiating Treatment With Romosozumab and Other Anti-osteoporosis Therapies (20190205)
United States
EU PAS number:
EUPAS37160
First published:
12/05/2025
StudyFinalised
Overall survival and incidence of adverse events in B-cell acute lymphoblastic leukemia (ALL) patients after allogeneic stem cell transplant: blinatumomab vs non-blinatumomab chemotherapy-- an analysis of the Center for International Blood and Marrow Transplant Research database (20170610) (Transplant outcomes among ALL in CIBMTR)
Austria
Belgium
Bulgaria
Canada
Croatia
Cyprus
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
United States
EU PAS number:
EUPAS33745
First published:
12/05/2025
StudyFinalised
Tarlatamab vs. Real-world Physicians’ Choice Therapies in Patients with Relapsed or Refractory Small Cell Lung Cancer After Two or More Prior Lines of Treatment: Patient-level Indirect Treatment Comparison (ITC) of DeLLphi-301 vs. Flatiron Real-world Data (20240049)
United States
EU PAS number:
EUPAS1000000298
First published:
12/05/2025
StudyFinalised
Retrospective Cohort Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
United States
EU PAS number:
EUPAS45952
First published:
12/05/2025
StudyOngoing
Tafamidis Pregnancy Surveillance Study
Canada
France
Germany
Japan
Portugal
Spain
United Kingdom
United States
EU PAS number:
EUPAS37119
First published:
12/05/2025
StudyOngoing
LONG-TERM NON-INTERVENTIONAL SAFETY STUDY OF EMICIZUMAB TREATMENT IN PATIENTS WITH MODERATE HAEMOPHILIA A AND SEVERE BLEEDING PHENOTYPE (STUDY BO44691, PASS)
Canada
France
United Kingdom
United States
EU PAS number:
EUPAS1000000174
First published:
12/05/2025
StudyPlanned
Non-interventional post-authorization study of belzutifan in adult patients with von Hippel-Lindau disease-associated renal cell carcinoma, pancreatic neuroendocrine tumor and/or central nervous system hemangioblastoma (MK-6482-026)
Canada
United States
EU PAS number:
EUPAS108114
First published:
12/05/2025
StudyOngoing
A regulatory requirement non-interventional study to monitor the safety and effectiveness of Spesolimab in Korean patients with flares with generalized pustular psoriasis
Korea, Republic of
EU PAS number:
EUPAS1000000278
First published:
12/05/2025
StudyPlanned
An Observational Study to Describe Women Exposed to Apremilast During Pregnancy and Infant Outcomes During the First Year of Life (20210218)
United States
EU PAS number:
EUPAS107685
First published:
12/05/2025
StudyFinalised
Real-World Impact of Bimekizumab on Disease Activity in axial spondyloarthritis patients including the EARLY subpopulation (EXPEDITE)
Austria
Belgium
European Union
France
Germany
Greece
Italy
Netherlands
Poland
Spain
Switzerland
United Kingdom
EU PAS number:
EUPAS1000000519
First published:
12/05/2025
StudyPlanned
Patient characteristics and utilization patterns of romosozumab in routine clinical practice: a European, multi-country, non-interventional study (PRIME)
Belgium
Germany
Greece
Italy
Spain
Sweden
Switzerland
United Kingdom
EU PAS number:
EUPAS1000000343
First published:
12/05/2025
StudyOngoing
Safety and effectiveness of RZV in adults ≥18 years of age with Systemic lupus erythematosus (SLE) or Multiple sclerosis (MS) (EPI-ZOSTER-041 VS US DB 215104)
United States
EU PAS number:
EUPAS107073
First published:
12/05/2025
StudyOngoing
An Open-Label, Observational, Prospective, Multicenter Study to Evaluate the Long-Term Efficacy and Safety of Perampanel as Monotherapy in Subjects Age 4 Years and Older with Focal Onset Seizures: PORTABLE Study
Japan
EU PAS number:
EUPAS1000000572
First published:
12/05/2025
StudyOngoing
TED-R13-002: A Prospective, Multi-center Registry for Patients with Short Bowel Syndrome (TED-R13-002: SBS Registry)
Argentina
Australia
Canada
Croatia
Czechia
Denmark
Finland
France
Germany
Italy
Norway
Slovenia
Spain
Sweden
United Kingdom
United States
EU PAS number:
EUPAS7973
First published:
12/05/2025
StudyOngoing
Periodic Knowledge, Attitudes, and Behavior (KAB) Survey of Certified Prescribers to Assess Understanding of the Risks with the BKEMV™ Risk Evaluation and Mitigation Strategy (REMS) (20240216)
United States
EU PAS number:
EUPAS1000000367
First published:
08/05/2025
StudyPlanned
Prospective Study to Assess Usage, Adherence, Effectiveness of Cabotegravir LA for Pre-Exposure Prophylaxis in the United States in the OPERA Cohort (219844)
United States
EU PAS number:
EUPAS1000000165
First published:
08/05/2025
StudyOngoing
Prospective non-interventional cohort study to assess safety and tolerability of 3Fluart 2024/2025 trivalent seasonal influenza vaccine in children, adolescents, adults and elderly subjects (3Fluart-H-35)
Hungary
EU PAS number:
EUPAS1000000177
First published:
08/05/2025
StudyFinalised
A retrospective matched cohort study on the association between herpes zoster vaccination and dementia and mild cognitive impairment using electronic health records (ZOSTER-122 AIML 222419)
United States
EU PAS number:
EUPAS107206
First published:
08/05/2025
StudyOngoing
Post-authorization safety study to evaluate the risks of myelodysplastic syndrome/acute myeloid leukemia and second primary malignancies in adult patients with platinum-sensitive, relapsed, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer receiving maintenance treatment with ZEJULA® (niraparib) (213705 - Zejula PASS 3000-04-001)
Germany
Italy
Netherlands
Spain
EU PAS number:
EUPAS29407
First published:
08/05/2025
StudyOngoing
Real-world use of enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer previously treated with chemotherapy and immunotherapy: a multicenter, retrospective, non-interventional study in France
France
EU PAS number:
EUPAS105591
First published:
07/05/2025
StudyFinalised
C16050: A national, prospective, non-interventional study of using NINLARO® in real world clinical practice
China
EU PAS number:
EUPAS30733
First published:
07/05/2025
StudyOngoing
Descriptive Study of the Incidence of Malignancy in Patients with Severe Asthma Overall and Among Those Receiving Benralizumab and Other Therapies, a Post Authorization Safety Study
Argentina
Bulgaria
Canada
Colombia
Denmark
Finland
Germany
Greece
Iceland
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Saudi Arabia
Singapore
Spain
Sweden
Taiwan
United Kingdom
United States
EU PAS number:
EUPAS26310
First published:
07/05/2025
StudyFinalised
The Information System for Research in Primary Care (SIDIAP)
First published:
07/05/2025
Spain
Data source
Human
Hospital discharge recordsOtherPharmacy dispensing recordsPrimary care medical recordsDrug utilisation study of Eliglustat for the treatment of Gaucher Disease Type 1 in Europe using electronic healthcare records (ELIGLC06913)
France
Germany
Israel
EU PAS number:
EUPAS34611
First published:
07/05/2025
StudyFinalised
Post-marketing study to assess the effectiveness of doravirine-included in highly active antiretroviral therapy (HAART) in HIV-1 infected adult Chinese patients (MK-1439-088)
China
EU PAS number:
EUPAS103993
First published:
07/05/2025
StudyFinalised
ELEVATE, a Global Observational Longitudinal Prospective Registry of Patients With Acute Hepatic Porphyria (AHP)
Belgium
France
Germany
Italy
Netherlands
Sweden
Switzerland
Taiwan
United Kingdom
United States
EU PAS number:
EUPAS43201
First published:
07/05/2025
StudyOngoing
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
Belgium
Canada
France
Germany
Israel
Italy
Netherlands
Spain
Switzerland
United Kingdom
United States
EU PAS number:
EUPAS43242
First published:
07/05/2025
StudyOngoing
Prospective Observational Study to Monitor and Assess the Safety of Amvuttra® [Vutrisiran] in a Real-World Cohort of hATTR Amyloidosis Patients
Brazil
Bulgaria
Denmark
France
Germany
Israel
Italy
Netherlands
Portugal
Spain
Taiwan
United Kingdom
United States
EU PAS number:
EUPAS108904
First published:
07/05/2025
StudyOngoing
ConTTRibute: A Global Observational Multicenter Long-Term Study of Patients with Transthyretin (TTR)-Mediated Amyloidosis (ATTR amyloidosis)
Brazil
Bulgaria
Denmark
France
Germany
Israel
Italy
Netherlands
Portugal
Spain
Taiwan
United States
EU PAS number:
EUPAS1000000381
First published:
07/05/2025
StudyOngoing
Prospective observational study to monitor and assess the safety of Onpattro® patisiran-LNP in a real-world cohort of hATTR amyloidosis patients
Brazil
Bulgaria
Denmark
France
Germany
Israel
Italy
Netherlands
Portugal
Spain
Taiwan
United Kingdom
United States
EU PAS number:
EUPAS40417
First published:
07/05/2025
StudyOngoing
InGef Research Database
First published:
07/05/2025
Germany
Data source
Human
Administrative healthcare records (e.g., claims)Research Repository @Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
First published:
07/05/2025
Italy
Data source
Human
Hospital discharge recordsHospital inpatient recordsHospital outpatient visit recordsOther